Skip to main content
OpenTrials

Clinical trial condition

Gonadal Disorders

Explore clinical trials studying Gonadal Disorders. Study availability and eligibility vary by location and protocol.

4,156 public trials 779 recruiting studies
Refine in advanced search Browse all conditions

Gonadal Disorders trial results

Active, Not Recruiting

A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)

NCT04783181

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +16 more
Locations
  • Ann and Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Lucas Research, Inc. Morehead City, North Carolina, United States
View Trial Details
Active, Not Recruiting

Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer

NCT05276973

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +32 more
Locations
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
  • Augusta University Medical Center Augusta, Georgia, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details
Active, Not Recruiting

A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients

NCT06682572

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Kurume University Hospital Kurume, Fukuoka, Japan
  • Mie University Hospital Tsu, Mie-ken, Japan
  • Tohoku University Hospital Sendai, Miyagi, Japan
View Trial Details
Active, Not Recruiting

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

NCT01844986

Conditions
Adnexal Diseases, Advanced Ovarian Cancer, BRCA Mutation, +24 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Providence Cancer Center Anchorage, Alaska, United States
  • St. Joseph's Hospital & Medical Center Phoenix, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 177 locations
View Trial Details
Active, Not Recruiting

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT03983954

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more
Locations
  • Shalby Hospital Ahmedabad, Gujarat, India
  • National Cancer Institute Jhajjar, Haryana, India
  • All India Institute of Medical Sciences New Delhi, India
  • PMCH (Pacific Medical College & Hospital) Udaipur, Rajasthan, India
View Trial Details

Related conditions